Loading…
Loading…
The latest trading day saw Altria (MO) settling at $68.17, representing a -1.03% change from its previous close.
Collecting $1,000 a month in dividends sounds simple until you realize the capital required shifts every time prices move, and choosing the wrong yield can leave you exposed to a dividend cut when you can least afford it.
MO's premium cigarette strategy remains central to profitability as Marlboro holds its premium position amid rising demand for discount brands.
Altria Group remains a compelling income alternative, yielding 6.4% after its 57th consecutive annual dividend increase and robust Q2 2026 results. MO's pricing power, high margins (64.8% smokeable segment), and investment-grade balance sheet underpin reliable cash flow despite secular volume declines. MO's valuation is attractive at 12.13x forward earnings and 13x FCF, with dividend growth outpacing comparable high-yield bonds after tax.
The Dividend Harvesting Portfolio has achieved a 45.8% ROI, generating $3,289.51 in forward annual dividend income from $28,800 invested. Portfolio yield stands at 7.83% (11.42% yield on cost), with a focus on compounding and reinvestment to drive long-term income growth. Recent additions include Pfizer for value and yield (>6%,
Social Security's projected 2027 COLA raise sounds promising until you realize retirees feel higher prices months before benefits catch up. Five blue-chip dividend stocks already pay yields that outpace that adjustment, and some have raised their payouts for decades straight.
Some investors have quietly built decades of rising income by owning stocks most people have never heard of, and five Dividend Champions with yields stretching past 7% are now drawing serious attention from Wall Street analysts.
Altria just handed shareholders a bigger check for the 60th time in 56 years, but negative operating cash flow last quarter and a vape unit bleeding billions in impairments raise a real question about whether the streak has a price.